The National Strategic Plan 2009-2012 on HIV and AIDS (NSP) is the result of more than a year of preparatory work, starting with the development of Rwanda's Economic Development and Poverty Reduction Strategy (EDPRS) 2008-2012, which sets out the overarching goals for the response to HIV and AIDS as... well as reaffirming Rwanda's commitment to a multi-sector response. In addition, a wide range of analyses carried out in 2007 and 2008 have helped to ensure that the NSP is based on the most up to date understanding of the epidemic, that the strategies are based on evidence of what works in Rwanda and elsewhere, and that the strengths and weaknesses of the systems and mechanisms for responding to HIV and AIDS are addressed through the NSP.
more
The seven essential features of practice for scaling up are described with great clarity. They are practical and universal, and encourage local innovation. They include policy, funding and local management structure, as well as working with all possible partners and developing local context adaptati...ons. The case studies give ideas and inspiration to develop new programmes and find ways around obstacles in existing programmes, especially through involving those with most at stake including users and their families and local community leaders
more
The guidance aspires
• To emphasize the 'need' to mainstream disaster risk reduction (DRR) in the health sector initiatives.
• To identify key approaches for mainstreaming DRR in the health sector in Myanmar, particularly in rural areas, based on the good practices, innovative approach...es and lessons learned of Government, UN agencies, NGOs and others involved in the Cyclone Nargis recovery.
• Identify key ‘vulnerabilities and opportunities’ for creating a ‘safer health system’ in Myanmar.
No publication year indicated.
more
“towards quality health and social welfare services”
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Enhancing Men’s Role in HIV Prevention
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries